Large-scale testing (Phase 3)Study completedNCT06497491
What this trial is testing
An Efficacy and Safety Study of GNR-086 (Canakinumab Biosimilar) and Ilaris® in Patients With Adult-onset Still's Disease
Who this might be right for
Still's Disease Adult Onset
AO GENERIUM 118